StoryNote
Log in
|
Sign up
In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAFV600E lung adenocarcinoma
by
/u/WalkingHorse
in
/r/LungCancerSupport
Read on Reddit
Upvotes:
1
Favorite this post:
Mark as read:
Your rating:
--
10
9
8
7
6
5
4
3
2
1
0
Add this post to a custom list
StoryNote